U.S. market Closed. Opens in 17 hours 8 minutes

IKT | Inhibikase Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.4600 - 1.6750
52 Week Range 0.7900 - 3.82
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 48,764
Average Volume 51,343
Shares Outstanding 7,216,150
Market Cap 10,535,579
Sector Healthcare
Industry Biotechnology
IPO Date 2020-12-23
P/E Ratio -0.44
Forward P/E Ratio N/A
EPS -3.32
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 8
Country USA
Website IKT
Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
*Chart delayed
Analyzing fundamentals for IKT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see IKT Fundamentals page.

Watching at IKT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on IKT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙